This review outlines the current state-of-the-art and potential future scenarios for transcatheter mitral valve repair and replacement technologies.
Answers are grounded in this paper and cite their sources.
Informs clinicians on transcatheter mitral options; leaves open the need for randomized trials to validate future scenarios.
Transcatheter mitral interventions has been developed to address an unmet clinical need and may be an alternative therapeutic option to surgery with the intent to provide symptomatic and prognostic benefit. Beyond MitraClip therapy, alternative repair technologies are being developed to expand the transcatheter intervention armamentarium. Recently, the feasibility of transcatheter mitral valve implantation in native non-calcified valves has been reported in very high-risk patients. Acknowledging the lack of scientific evidence to date, it is difficult to predict what the ultimate future role of transcatheter mitral valve interventions will be. The purpose of the present report is to review the current state-of-the-art of mitral valve intervention, and to identify the potential future scenarios, which might benefit most from the transcatheter repair and replacement devices under development.
No takes yet. Share an insight, caveat, or question.
Maisano et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: